Skip to main content
. 2021 Nov 23;14(12):1206. doi: 10.3390/ph14121206

Table 1.

Inhibition of PgQC by tetrahydroimidazo[4,5-c]pyridines with alkyl and acyl modifications.

graphic file with name pharmaceuticals-14-01206-i001.jpg R1 R2 R3 Ki [µM]
6a graphic file with name pharmaceuticals-14-01206-i002.jpg - no inhibition @ 10 µM
7a graphic file with name pharmaceuticals-14-01206-i002.jpg H H 0.909 ± 0.005
7b graphic file with name pharmaceuticals-14-01206-i003.jpg H H 6.470 ± 0.400
7c graphic file with name pharmaceuticals-14-01206-i002.jpg -CH2OCH2- 1.755 ± 0.145
7d graphic file with name pharmaceuticals-14-01206-i002.jpg CH3 - 3.080 ± 0.040
7e graphic file with name pharmaceuticals-14-01206-i002.jpg graphic file with name pharmaceuticals-14-01206-i002.jpg - no inhibition @ 10 µM
graphic file with name pharmaceuticals-14-01206-i004.jpg
8a graphic file with name pharmaceuticals-14-01206-i002.jpg H H 0.435 ± 0.015
8b graphic file with name pharmaceuticals-14-01206-i003.jpg H H 1.680 ± 0.080
8c graphic file with name pharmaceuticals-14-01206-i005.jpg H H 1.750 ± 0.060
8d graphic file with name pharmaceuticals-14-01206-i006.jpg H H 1.575 ± 0.025